Cargando…

Intravenous allogeneic multilineage‐differentiating stress‐enduring cells in adults with dystrophic epidermolysis bullosa: a phase 1/2 open‐label study

Detalles Bibliográficos
Autores principales: Fujita, Y., Nohara, T., Takashima, S., Natsuga, K., Adachi, M., Yoshida, K., Shinkuma, S., Takeichi, T., Nakamura, H., Wada, O., Akiyama, M., Ishiko, A., Shimizu, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359848/
https://www.ncbi.nlm.nih.gov/pubmed/33656198
http://dx.doi.org/10.1111/jdv.17201
_version_ 1783737621377187840
author Fujita, Y.
Nohara, T.
Takashima, S.
Natsuga, K.
Adachi, M.
Yoshida, K.
Shinkuma, S.
Takeichi, T.
Nakamura, H.
Wada, O.
Akiyama, M.
Ishiko, A.
Shimizu, H.
author_facet Fujita, Y.
Nohara, T.
Takashima, S.
Natsuga, K.
Adachi, M.
Yoshida, K.
Shinkuma, S.
Takeichi, T.
Nakamura, H.
Wada, O.
Akiyama, M.
Ishiko, A.
Shimizu, H.
author_sort Fujita, Y.
collection PubMed
description
format Online
Article
Text
id pubmed-8359848
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-83598482021-08-17 Intravenous allogeneic multilineage‐differentiating stress‐enduring cells in adults with dystrophic epidermolysis bullosa: a phase 1/2 open‐label study Fujita, Y. Nohara, T. Takashima, S. Natsuga, K. Adachi, M. Yoshida, K. Shinkuma, S. Takeichi, T. Nakamura, H. Wada, O. Akiyama, M. Ishiko, A. Shimizu, H. J Eur Acad Dermatol Venereol Letters to the Editor John Wiley and Sons Inc. 2021-03-14 2021-08 /pmc/articles/PMC8359848/ /pubmed/33656198 http://dx.doi.org/10.1111/jdv.17201 Text en © 2021 The Authors. Journal of the European Academy of Dermatology and Venereology published by John Wiley & Sons Ltd on behalf of European Academy of Dermatology and Venereology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Letters to the Editor
Fujita, Y.
Nohara, T.
Takashima, S.
Natsuga, K.
Adachi, M.
Yoshida, K.
Shinkuma, S.
Takeichi, T.
Nakamura, H.
Wada, O.
Akiyama, M.
Ishiko, A.
Shimizu, H.
Intravenous allogeneic multilineage‐differentiating stress‐enduring cells in adults with dystrophic epidermolysis bullosa: a phase 1/2 open‐label study
title Intravenous allogeneic multilineage‐differentiating stress‐enduring cells in adults with dystrophic epidermolysis bullosa: a phase 1/2 open‐label study
title_full Intravenous allogeneic multilineage‐differentiating stress‐enduring cells in adults with dystrophic epidermolysis bullosa: a phase 1/2 open‐label study
title_fullStr Intravenous allogeneic multilineage‐differentiating stress‐enduring cells in adults with dystrophic epidermolysis bullosa: a phase 1/2 open‐label study
title_full_unstemmed Intravenous allogeneic multilineage‐differentiating stress‐enduring cells in adults with dystrophic epidermolysis bullosa: a phase 1/2 open‐label study
title_short Intravenous allogeneic multilineage‐differentiating stress‐enduring cells in adults with dystrophic epidermolysis bullosa: a phase 1/2 open‐label study
title_sort intravenous allogeneic multilineage‐differentiating stress‐enduring cells in adults with dystrophic epidermolysis bullosa: a phase 1/2 open‐label study
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359848/
https://www.ncbi.nlm.nih.gov/pubmed/33656198
http://dx.doi.org/10.1111/jdv.17201
work_keys_str_mv AT fujitay intravenousallogeneicmultilineagedifferentiatingstressenduringcellsinadultswithdystrophicepidermolysisbullosaaphase12openlabelstudy
AT noharat intravenousallogeneicmultilineagedifferentiatingstressenduringcellsinadultswithdystrophicepidermolysisbullosaaphase12openlabelstudy
AT takashimas intravenousallogeneicmultilineagedifferentiatingstressenduringcellsinadultswithdystrophicepidermolysisbullosaaphase12openlabelstudy
AT natsugak intravenousallogeneicmultilineagedifferentiatingstressenduringcellsinadultswithdystrophicepidermolysisbullosaaphase12openlabelstudy
AT adachim intravenousallogeneicmultilineagedifferentiatingstressenduringcellsinadultswithdystrophicepidermolysisbullosaaphase12openlabelstudy
AT yoshidak intravenousallogeneicmultilineagedifferentiatingstressenduringcellsinadultswithdystrophicepidermolysisbullosaaphase12openlabelstudy
AT shinkumas intravenousallogeneicmultilineagedifferentiatingstressenduringcellsinadultswithdystrophicepidermolysisbullosaaphase12openlabelstudy
AT takeichit intravenousallogeneicmultilineagedifferentiatingstressenduringcellsinadultswithdystrophicepidermolysisbullosaaphase12openlabelstudy
AT nakamurah intravenousallogeneicmultilineagedifferentiatingstressenduringcellsinadultswithdystrophicepidermolysisbullosaaphase12openlabelstudy
AT wadao intravenousallogeneicmultilineagedifferentiatingstressenduringcellsinadultswithdystrophicepidermolysisbullosaaphase12openlabelstudy
AT akiyamam intravenousallogeneicmultilineagedifferentiatingstressenduringcellsinadultswithdystrophicepidermolysisbullosaaphase12openlabelstudy
AT ishikoa intravenousallogeneicmultilineagedifferentiatingstressenduringcellsinadultswithdystrophicepidermolysisbullosaaphase12openlabelstudy
AT shimizuh intravenousallogeneicmultilineagedifferentiatingstressenduringcellsinadultswithdystrophicepidermolysisbullosaaphase12openlabelstudy